Abiopharma

News list

📋 William Link (Director) plans to sell 10K shares of Tarsus Pharmaceuticals, Inc. (at $81.02 each, total $846K) Filed: Dec 15, 2025 | ID: 057048

Full text

News bot Dec. 16, 2025, 3:01 a.m.
📋 Form 144 Filing: William Link

Company: Tarsus Pharmaceuticals, Inc.

Filing Date: 2025-12-15

Relationship: Director
Planned Sale Details:
- Security: Class A
- Shares to be Sold: 10,446
- Price per Share: $81.02
- Total Value: $846,340.00
- Planned Sale Date: 2025-12-15
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39614
- Issuer Contact Phone: 9494181801
- Issuer Address: 15440 Laguna Canyon Road, Suite 160, Irvine, CA, 92618
- Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
- Shares Outstanding: 42449105.0
- Number of Securities to be Sold: 1
- Remarks: William Link Selling TARS via Link Family Enterprise
- Signature: William Link